SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX)

Historical Holders from Q1 2019 to Q3 2025

Symbol
SWTX
CUSIP
85205L107
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
75.6M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
75.1M
Holdings value
$3.53B
% of all portfolios
0.02%
Grand Portfolio weight change
+0%
Number of holders
220
Number of buys
132
Number of sells
-199
Average Value change %
+0%
Average buys %
+0.017%
Average sells %
-0.014%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 9.62% $256M 7.16M The Vanguard Group Dec 31, 2024
GOLDMAN SACHS GROUP INC 5.6% $199M 4.23M THE GOLDMAN SACHS GROUP, INC. Jun 30, 2025
Hudson Bay Capital Management LP 5.22% $182M 3.94M Hudson Bay Capital Management LP Jun 30, 2025
Deep Track Capital, LP 4.65% $124M 3.46M Deep Track Capital, LP Dec 31, 2024
FMR LLC 1.7% $44.9M 1.26M FMR LLC Apr 30, 2025

Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$40.5M 0
2025 Q2 75.1M $3.53B +$109M $46.99 220
2025 Q1 73.7M $3.25B -$236M $44.13 304
2024 Q4 80.8M $2.92B -$110M $36.13 213
2024 Q3 80.5M $2.58B +$40.3M $32.04 223
2024 Q2 77.1M $2.9B -$72.4M $37.67 205
2024 Q1 77.9M $3.83B +$155M $49.22 213
2023 Q4 57.8K $2.12M +$130K $36.87 2
2023 Q3 67.9M $1.57B -$32.5M $23.12 142
2023 Q2 69.3M $1.81B +$82.6M $26.22 137
2023 Q1 66.2M $1.7B -$5.03M $25.74 144
2022 Q4 66.5M $1.72B +$69.5M $26.01 134
2022 Q3 63.2M $1.8B +$224M $28.53 141
2022 Q2 55.3M $1.36B +$58.4M $24.62 135
2022 Q1 49.2M $2.77B +$223M $56.44 127
2021 Q4 45.3M $2.81B +$24.6M $61.98 138
2021 Q3 44.9M $2.85B +$37.9M $63.44 138
2021 Q2 44.6M $3.68B +$71M $82.41 131
2021 Q1 43.6M $3.21B +$40.5M $73.57 132
2020 Q4 42.8M $3.1B +$399M $72.52 120
2020 Q3 37.4M $1.78B +$127M $47.67 87
2020 Q2 34.7M $1.46B +$81.8M $42.00 76
2020 Q1 33M $891M +$24.7M $27.00 68
2019 Q4 31.9M $1.23B +$27.8M $38.49 56
2019 Q3 31.2M $677M +$677M $21.68 43
2019 Q2 53.9K $4.45M $0 $82.41 1
2019 Q1 53.9K $4.45M $0 $82.41 1